EUVIMEDOpdag EUVIMED
LeserbriefOpen access · CC BY-NC-ND 4.0

Efficacy of FP ‐025: A novel matrix metalloproteinase‐12 ( MMP ‐12) inhibitor in murine allergic asthma

Lara Ravanetti, Tamara Dekker, Lihui Guo, Annemiek Dijkhuis, Barbara S Dierdorp, Zuzana Diamant, Sandrine Florquin, René Lutter

Allergy · 2023-02 · 78 (2) · 559-562

DOI: 10.1111/all.15513 ↗

At a glance

Leserbrief in Allergy, published online on 2022-09-18. Written by Lara Ravanetti and 7 co-authors. Institution: Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Center (Location AMC), Amsterdam, The…. Major MEDLINE topics: Matrix Metalloproteinase 12, Asthma. Cited 8 times so far (Crossref); 6 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

reasons the number of authors shown on this cover page is limited to 10 maximum.

Subjects

MeSH terms (MEDLINE)

Matrix Metalloproteinase 12AsthmaHumansAnimalsMiceLungSulfur CompoundsTissue Inhibitor of Metalloproteinase-1

Substances

FP-025Matrix Metalloproteinase 12Sulfur CompoundsTissue Inhibitor of Metalloproteinase-1

Authors and institutions

  • Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Center (Location AMC), Amsterdam, The Netherlands.
  • Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Department of Respiratory Medicine and Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.
  • Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
  • Department of Pathology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Center (Location AMC), Amsterdam, The Netherlands.

Cite

APA

Ravanetti, L., Dekker, T., Guo, L., Dijkhuis, A., Dierdorp, B. S., Diamant, Z., Florquin, S., & Lutter, R. (2023). Efficacy of FP ‐025: A novel matrix metalloproteinase‐12 ( MMP ‐12) inhibitor in murine allergic asthma. Allergy, 78(2), 559-562. https://doi.org/10.1111/all.15513

Vancouver

Ravanetti L, Dekker T, Guo L, Dijkhuis A, Dierdorp BS, Diamant Z, et al. Efficacy of FP ‐025: A novel matrix metalloproteinase‐12 ( MMP ‐12) inhibitor in murine allergic asthma. Allergy. 2023;78(2):559-562. doi:10.1111/all.15513

BibTeX
@article{Ravanetti2023,
  author = {Ravanetti, Lara and Dekker, Tamara and Guo, Lihui and Dijkhuis, Annemiek and Dierdorp, Barbara S and Diamant, Zuzana and Florquin, Sandrine and Lutter, René},
  title = {Efficacy of FP ‐025: A novel matrix metalloproteinase‐12 ( MMP ‐12) inhibitor in murine allergic asthma},
  journal = {Allergy},
  year = {2023},
  volume = {78},
  number = {2},
  pages = {559--562},
  doi = {10.1111/all.15513}
}
Start for free →